OASMIA PHARMACEUTICAL AB (OASMY)
Institutional ownership reported to the SEC as of Q2 2019, across 3 quarters.
3
Reporting holders
$38.0K
Reported value
0.0%
Held as options
-3
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Compagnie Lombard Odier SCmA | $33.0K | 33,300 | 0.00% | 3q | HELD |
| UBS Group AG | $3.0K | 2,723 | 0.00% | 3q | -24.9% |
| FNY Investment Advisers, LLC | $2.0K | 2,600 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2019 | 3 | $38.0K | 38,623 | 1 | 0 | 1 | 0.0% |
| Q1 2019 | 6 | $187.0K | 82,487 | 2 | 0 | 3 | 0.0% |
| Q4 2018 | 4 | $323.0K | 103,716 | 1 | 0 | 0 | 0.0% |